- Home
- LGVN vs XAIR Comparison
LGVN vs XAIR Comparison
Compare LGVN & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- XAIR
- Stock Information
- Founded
- LGVN 2014
- XAIR 2011
- Country
- LGVN United States
- XAIR United States
- Employees
- LGVN N/A
- XAIR N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- XAIR Medical/Dental Instruments
- Sector
- LGVN Health Care
- XAIR Health Care
- Exchange
- LGVN Nasdaq
- XAIR Nasdaq
- Market Cap
- LGVN 26.0M
- XAIR 26.0M
- IPO Year
- LGVN 2021
- XAIR N/A
- Fundamental
- Price
- LGVN $1.70
- XAIR $0.42
- Analyst Decision
- LGVN Strong Buy
- XAIR Strong Buy
- Analyst Count
- LGVN 3
- XAIR 4
- Target Price
- LGVN $8.67
- XAIR $3.67
- AVG Volume (30 Days)
- LGVN 314.6K
- XAIR 2.3M
- Earning Date
- LGVN 02-25-2025
- XAIR 02-10-2025
- Dividend Yield
- LGVN N/A
- XAIR N/A
- EPS Growth
- LGVN N/A
- XAIR N/A
- EPS
- LGVN N/A
- XAIR N/A
- Revenue
- LGVN $1,852,000.00
- XAIR $2,342,000.00
- Revenue This Year
- LGVN $208.32
- XAIR $230.80
- Revenue Next Year
- LGVN $43.96
- XAIR $265.55
- P/E Ratio
- LGVN N/A
- XAIR N/A
- Revenue Growth
- LGVN 141.46
- XAIR 685.91
- 52 Week Low
- LGVN $0.77
- XAIR $0.30
- 52 Week High
- LGVN $10.30
- XAIR $2.17
- Technical
- Relative Strength Index (RSI)
- LGVN 41.48
- XAIR 51.29
- Support Level
- LGVN $1.72
- XAIR $0.34
- Resistance Level
- LGVN $1.89
- XAIR $0.38
- Average True Range (ATR)
- LGVN 0.14
- XAIR 0.06
- MACD
- LGVN -0.00
- XAIR 0.00
- Stochastic Oscillator
- LGVN 8.47
- XAIR 40.62
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.